Halozyme Therapeutics shares owned by Jackson Creek Investment Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Jackson Creek Investment Advisors
from 13F filings
Historical chart of Jackson Creek Investment Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Jackson Creek Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Jackson Creek Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.7M | 23k | 73.35 |
| 2025-06-30 | $1.2M | 23k | 52.02 |
| 2025-03-31 | $1.7M | 26k | 63.80 |
| 2024-12-31 | $1.3M | 26k | 47.79 |
| 2022-06-30 | $922k | 19k | 48.92 |
| 2021-12-31 | $1.0M | 25k | 40.23 |
| 2021-09-30 | $1.1M | 27k | 40.69 |
| 2021-03-31 | $1.2M | 28k | 41.69 |
| 2020-12-31 | $1.2M | 29k | 42.70 |
| 2020-09-30 | $1.1M | 40k | 26.27 |
More positions owned by Jackson Creek Investment Advisors
View all positions for Jackson Creek Investment Advisors